All PlansCoverageMedium impact
Recall: Metformin ER
UPMC Health Plan·Family Medicine, Internal Medicine, Endocrinology +1 more·Pharmacy
We identified it
Jun 20, 2026
Summary
Viona Pharmaceuticals has recalled 33 lots of Metformin Hydrochloride Extended-Release Tablets 750mg due to impurity levels exceeding FDA standards. Healthcare providers should review patient medications and consider alternative treatments for affected lots.
Action Required
Immediately: Clinical staff should review current patients on Metformin ER 750mg to identify if they have recalled lots from Viona Pharmaceuticals. Providers must contact affected patients to discontinue recalled medication and prescribe alternative Metformin formulations. Billing team should be prepared for potential increase in office visits and new prescriptions related to medication changes.